News

Mobile Medical

News

Pharmacy - 10/13/2010

Targeted disinfection measures - no more cracking nuts with sledgehammers

Düsseldorf, Oktober 2010 Noroviruses, Clostridium difficile and flu viruses, such as H1N1, have entered everyday life in the form of explosive media reports. Global increases in infection rates due to greater mobility among the world’s population have become general knowledge for some time now.
Due to the number of reports on various infectious diseases and hygiene scandals in hospitals, fear of becoming infected with harmful pathogens is increasing among health service staff – not to mention the patients.

Pharmacy - 07/13/2010

New research identifies promising leads to follow in search for medicines to fight malaria

Study published in Nature suggests kinase inhibitors and targets within human blood cells offer promising options to explore.

Pharmacy - 11/30/1999

HARVARD OptiCaps

THE SYNERGY of Harvard Cement & Capsule

Service

News

04/19/2012

seca mBCA 515 – why measure body composition?

Obesity or muscle wasting disease? A patient's body composition data are essential for the diagnosis and treatment of weight-related disorders. Too much fat in the body is …

04/17/2012

Market launch xantasil®: new alginate substitute from Heraeus leaves a lasting impression

Hanau, Germany, 16.04.2012.
xantasil® is a new medium-viscosity addition-curing silicone by Heraeus Dental, which will be launched on the markets in the USA as well as …

04/01/2012

LEICA MICROSYSTEMS INTRODUCES TISSUE IA 2.0* QUANTITATIVE IMAGE ANALYSIS FLUORESCENCE AND BRIGHTFIELD ANALYSIS FOR DIGITAL PATHOLOGY

Wetzlar, Germany, March 30, 2012—
Leica Microsystems announces the release of Tissue IA 2.0, high performance image analysis for discovery research. Combining fluorescence …

03/23/2012

ZOLL X SERIES MONITOR/DEFIBRILLATOR GRANTED 510(K) CLEARANCE BY U.S. FOOD AND DRUG ADMINISTRATION

New Small, Light, Powerful Device Designed for Emergency Medical Services …

03/01/2012

Bavarian Nordic Submits a Marketing Application for its Smallpox Vaccine to the European Medicines Agency

KVISTGAARD, Denmark, March 1, 2012 - Bavarian Nordic A/S (OMX: BAVA) announced today that it has submitted a Marketing Authorization Application (MAA) to the European Medicines …